Quality of life and financial toxicity after (chemo)radiation therapy in head and neck cancer: are there any sex- or gender-related differences?

The purpose of this article is to discuss the published evidence related to quality of life (QoL) and financial toxicity (FT) differences between female and male head and neck cancer patients treated with (chemo)radiotherapy. There is a need of promoting methods for assessing QoL difference between female and male patients in order to set up early rehabilitation, psychosocial care, and lifestyle interventions, as well as setting up specific interventions for minimizing financial stress.

Automated summary

This article discusses the differences in quality of life and financial toxicity between female and male head and neck cancer patients undergoing (chemo)radiotherapy, emphasizing the importance of assessing these differences and proposing interventions and care recommendations.